Ginkgo biloba: indications, mechanisms, and safety
Abstract
Ginkgo biloba special extract (EGb761) is used in most randomized controlled trials, with indications including cognition and memory in Alzheimer disease, age-associated dementia, cerebral insufficiency and intermittent claudication. Mechanisms include increasing cerebral blood flow and antioxidant, anti-inflammatory and antiplatelet effects. Possible interactions with warfarin, MAO inhibitors and other drugs are reviewed for safety.
Referenced for these plants
How to cite
Diamond, B.J. and Bailey, M.R (2013) 'Ginkgo biloba: indications, mechanisms, and safety', Psychiatric Clinics of North America, 36(1), pp. 73-83. doi:10.1016/j.psc.2012.12.006
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.